No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
H.C. Wainwright Maintains Citius Pharmaceuticals(CTXR.US) With Buy Rating, Maintains Target Price $4
H.C. Wainwright Maintains Citius Pharmaceuticals(CTXR.US) With Buy Rating, Cuts Target Price to $4
Citius Pharmaceuticals Poised for Growth With Key Milestones and Promising Product Pipeline
12 Health Care Stocks Moving In Tuesday's Intraday Session
Citius Pharmaceuticals Announces $2 Million Registered Direct Offering of Common Stock
D. Boral Capital Maintains Buy on Citius Pharmaceuticals, Maintains $9 Price Target